Recombinant Human FXYD domain-containing ion transport regulator 5 (FXYD5), partial

中文名稱：

人FXYD5重組蛋白
貨號：

CSB-YP842655HU
說明書：

MSDS Datasheet
規(guī)格：
來源：

Yeast
其他：

中文名稱：

人FXYD5重組蛋白
貨號：

CSB-EP842655HU
說明書：

MSDS Datasheet
規(guī)格：
來源：

E.coli
其他：

中文名稱：

人FXYD5重組蛋白
貨號：

CSB-EP842655HU-B
說明書：

MSDS Datasheet
規(guī)格：
來源：

E.coli
共軛：

Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
其他：

中文名稱：

人FXYD5重組蛋白
貨號：

CSB-BP842655HU
說明書：

MSDS Datasheet
規(guī)格：
來源：

Baculovirus
其他：

中文名稱：

人FXYD5重組蛋白
貨號：

CSB-MP842655HU
說明書：

MSDS Datasheet
規(guī)格：
來源：

Mammalian cell
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關產(chǎn)品
靶點詳情

產(chǎn)品詳情

純度：

>85% (SDS-PAGE)
基因名：

FXYD5
Uniprot No.：

Q96DB9
別名：

FXYD5; DYSAD; IWU1; HSPC113; UNQ2561/PRO6241FXYD domain-containing ion transport regulator 5; Dysadherin
種屬：

Homo sapiens (Human)
蛋白長度：

Partial
蛋白標簽：

Tag?type?will?be?determined?during?the?manufacturing?process.

The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
產(chǎn)品提供形式：

Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
復溶：

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
儲存條件：

Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
保質(zhì)期：

The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
貨期：

Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
注意事項：

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet ：

Please contact us to get it.

產(chǎn)品評價

靶點詳情

功能：

Involved in down-regulation of E-cadherin which results in reduced cell adhesion. Promotes metastasis.
基因功能參考文獻：
1. the ratio between FXYD5 and alpha1-beta1 heterodimer determines whether the Na,K-ATPase acts as a positive or negative regulator of intercellular adhesion. PMID: 27142834
2. Knockdown of FXYD5 in MDA-MB-231 breast cancer cells largely decreases expression and secretion of the chemokine CCL2 (MCP-1). A related effect has also been observed in renal cell carcinoma cells. PMID: 27006401
3. Study demonstrated that the expression of FXYD1, FXYD3 and FXYD5 is elevated in the lungs of Acute respiratory distress syndrome patients PMID: 26410457
4. Dysadherin-silenced side population cells exhibited reduced expression of Bcl-2 and Bax compared with that prior to silencing. PMID: 26458963
5. we are focusing on the role of dysadherin in E-cadherin downregulation, the various expression patterns of the molecule in head and neck cancer PMID: 22105147
6. Findings suggest that dysadherin might contribute to breast cancer progression through AKT activation. PMID: 22494103
7. These results suggest a role of let-7a down-regulation in the development of thyroid neoplasias of the follicular histotype, likely regulating dysadherin protein expression levels. PMID: 22965940
8. Data show that osteoblasts are the major cell type of the bone marrow that affect RCC cells by secreting factors that increase the expression of dysadherin and CCL2 in the tumor cells leading to enhanced cell migration. PMID: 21328336
9. This is the first report on expression of dysadherin in the male gonad and in spermatozoa. PMID: 21774927
10. Overexpression of Snail, Slug, and dysadherin and activation of Wnt and PI3K/Akt signaling was associated with inactivated E-cadherin in the spindle cells of monophasic fibrous synovial sarcomas. PMID: 21809991
11. Combined dysadherin-positive expression and E-cadherin-negative expression may be valuable information for predicting aggressive tumor behavior of differentiated-type gastric carcinoma with submucosal invasion PMID: 21239043
12. transfection of dysadherin cDNA into the liver cancer cell line PLC/PRF/5 enhanced the properties of cencer stem cells, including anti-apoptosis, their sphere-forming ability, side population phenotype, and tumor initiation ability in vivo PMID: 20952084
13. In lung carcinomas dysadherin expression seems to reflect tumour aggressiveness and may be considered a positive marker of poor prognosis when considered alone or/and in combination with down-regulation of E-cadherin. PMID: 20712010
14. The detection of dysadherin in tumors and cytokeratin in the lymph nodes may be a potential significant indicator of a poor prognosis for patients who undergo complete resection of stage I non-small cell lung cancer PMID: 20944097
15. We report the cloning and characterization of a cancer-associated cell membrane glycoprotein recognized by mAb NCC-3G10. PMID: 11756660
16. dysadherin expression was significantly associated with the prognosis, occurrence of secondary undifferentiated carcinomas, size of the primary tumor, and metastasis to the regional lymph nodes and lungs PMID: 12970317
17. dysadherin has a role in hematogenous metastasis of gastric cancer PMID: 15102690
18. Dysadherin and E-cadherin expression may help to predict the prognosis of patients with ESCC (esophageal squamous cell carcinoma). PMID: 15459499
19. Dysadherin is able to modulate actin structures, stimulate cell motility, and contribute directly to the metastatic potential of human pancreatic cancer cells. PMID: 15466191
20. dysadherin may be a valuable prognostic marker in cervical carcinoma. PMID: 15619642
21. Over expression of dysadherin is associated with cutaneous malignant melanoma PMID: 15751018
22. In testicular tumours, as in other neoplasms, dysadherin downregulates E-cadherin expression, at least in part PMID: 16333245
23. Found in trophoblasts in both normal and abnormal pregnancies. PMID: 17084448
24. Dysadherin may play an important role in breast cancer progression by promoting invasion. PMID: 17437014
25. Recent work that has provided insights into possible mechanisms of action of dysadherin in the cancer progression process was reviewed. PMID: 17442482
26. FXYD5 is upregulated in cystic fibrosis epithelia which may exacerbate the Na(+) hyperabsorption and surface liquid dehydration observed in cystic fibrosis. PMID: 18263667
27. Increased dysadherin expression is possibly one of the post-transcriptional mechanisms responsible for E-cadherin downregulation in thyroid papillary neoplasia PMID: 18677652
28. The dysadherin expression level was significantly correlated with gastrointestinal stromal tumor risk stratification. PMID: 19217217
顯示更多

收起更多
亞細胞定位：

Membrane; Single-pass type I membrane protein.
蛋白家族：

FXYD family
數(shù)據(jù)庫鏈接：

HGNC: 4029

OMIM: 606669

KEGG: hsa:53827

STRING: 9606.ENSP00000344254

UniGene: Hs.333418